Virios therapeutics ceo greg duncan to present at the share™️ series investor event on monday, september 18, 2023

Atlanta, sept. 12, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases such as fibromyalgia (“fm”) and long-covid (“lc”), announced today that greg duncan, chairman and chief executive officer, will present at the share™️ series monday management update for investors on monday, september 18, 2023, at 11:00 am et.
VIRI Ratings Summary
VIRI Quant Ranking